Related Experiment Video
Updated: Jun 12, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
COVID-19 infection in patients with intestinal failure: UK experience
P J Allan1, T Ambrose1, C Mountford2
1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Insights
COVID-19 significantly impacted patients with intestinal failure (IF), particularly those requiring home parenteral nutrition (HPN). This study highlights infection rates and outcomes in IF patients during the pandemic.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Public Health
Background:
- The direct impact of the COVID-19 pandemic on patients with intestinal failure (IF) remains largely undescribed.
- Patients with IF, especially those reliant on long-term parenteral nutrition, may represent a vulnerable population during infectious disease outbreaks.
Purpose of the Study:
- To evaluate the infection rates, clinical presentations, and outcomes of COVID-19 in patients with types 2 and 3 intestinal failure.
- To assess the specific risks and consequences for individuals dependent on home parenteral nutrition (HPN).
Main Methods:
- A nationwide study was conducted across UK IF centers.
- Data were collected on patients with types 2 and 3 IF who contracted COVID-19 between March and August 2020.
- Infection rates were compared between HPN-dependent patients and hospitalized patients with type 2 IF.
Main Results:
- A total of 45 patients with IF contracted COVID-19.
- Infection rates were 1.2% for HPN-dependent adults and 6.4% for hospitalized type 2 IF adults.
- The mortality rate directly attributed to COVID-19 was 6.7% among infected patients with types 2 or 3 IF.
Conclusions:
- This is the first study to report on COVID-19 outcomes in a substantial cohort of patients requiring long-term parenteral nutrition.
- Implementing strategies to minimize nosocomial transmission in both hospital and community settings is crucial for protecting this vulnerable patient group.
Background:
The direct effect of the coronavirus disease 2019 (COVID-19) pandemic on patients with intestinal failure (IF) has not been described.
Methods:
We conducted a nationwide study of UK IF centers to evaluate the infection rates, presentations, and outcomes in patients with types 2 and 3 IF.
Results:
A total of 45 patients with IF contracted COVID-19 between March and August 2020; this included 26 of 2191 (1.2%) home parenteral nutrition (HPN)-dependent adults and 19 of 298 (6.4%) adults hospitalized with type 2 IF. The proportion of patients receiving nursing care for HPN administration was higher in those with community-acquired COVID-19 (66.7%) than the proportion in the entire HPN cohort (26.1%; P < .01). Two HPN-dependent and 1 hospitalized patient with type 2 IF died as a direct consequence of the virus (6.7% of 45 patients with types 2 or 3 infected).
Conclusion:
This is the first study to describe the outcomes of COVID-19 in a large cohort of patients requiring long-term PN. Methods to reduce hospital and community nosocomial spread would likely be beneficial.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Bacterial Gastroenteritis
Giardiasis
Intestinal Obstruction I: Introduction
Intestinal Obstruction II: Pathophysiology
Inflammatory Bowel Disease IV: Clinical Manifestations

